Sirnaomics Secures $105 Million in Series E Financing

Proceeds to Fund Development of Novel RNAi Therapeutics for Cancers, Viral Infections, Fibrosis, and Metabolic Diseases GAITHERSBURG, Md. and SUZHOU BIOBAY, China, July 1, 2021 -- (Healthcare Sales & Marketing Network) -- Sirnaomics Ltd., a leading bio... Biopharmaceuticals, Venture Capital Sirnaomics, RNAi therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news